Compare NBP & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBP | SOPH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Switzerland |
| Employees | 32 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 367.7M |
| IPO Year | N/A | 2021 |
| Metric | NBP | SOPH |
|---|---|---|
| Price | $2.56 | $5.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $9.00 | $7.50 |
| AVG Volume (30 Days) | ★ 867.7K | 87.1K |
| Earning Date | 04-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $2.58 |
| 52 Week High | $5.19 | $5.70 |
| Indicator | NBP | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 56.70 |
| Support Level | $2.10 | $4.54 |
| Resistance Level | $3.80 | $5.30 |
| Average True Range (ATR) | 0.22 | 0.30 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 65.67 | 63.01 |
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.